Alexion Pharmaceuticals
Toby Freyman is an accomplished executive in the pharmaceutical and biotechnology sectors, currently serving as Vice President of Business Development at Alexion Pharmaceuticals, Inc. since March 2024. Previously, Toby held key leadership roles at BeiGene, Takeda, Shire, Arsenal Medical, CRA International, and Boston Scientific Corporation, contributing expertise in business development and strategic marketing across various functions, including rare diseases and genetic disorders. Toby's educational background includes a Ph.D. in Materials Engineering from the Massachusetts Institute of Technology and a BS in Engineering Physics from Syracuse University, supplemented by study at City, University of London.
This person is not in any offices
Alexion Pharmaceuticals
44 followers
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders.